Tag: CIRSE 2018
Together, IO and RO can increase the scope of local tumour...
Bringing interventional oncology (IO) and radiation oncology (RO) closer together would yield more than important logistical gains for IO; it would open up a...
Stem cell therapy is the future of critical limb ischaemia management
Addressing the audience at the 33rd annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 22–25 September, Lisbon, Portugal), Sanjiv Sharma...
Appropriate patient and device selection and multidisciplinary team discussion make for...
Raman Uberoi (Oxford, UK) tells Interventional News at CIRSE 2018 in Lisbon, Portugal, that offering any treatment for abdominal aortic aneurysms, be it endovascular...
A “mediocre success rate” found for coil embolization to obtain intrahepatic...
Coil embolization of hepatic arteries to induce redistribution of blood flow and microspheres has a mediocre success rate, concluded a recent study presented by...
Lessons from randomised controlled trials utilising SIRT in liver cancer
A recent session at CIRSE 2018 sought to go beyond the headline findings from a number of recent randomised controlled trials (RCTs) in interventional...
Interim results of the Lutonix drug-coated balloon in a complex patient...
This article is sponsored by BD.
In a complex patient population with advanced, symptomatic below-the-knee peripheral artery disease, treatment with the Lutonix drug-coated balloon (BD)...
Covered stent provides greater patency than angioplasty alone in AV fistulae
The Covera vascular covered stent (BD) has a superior six-month primary patency rate than standard balloon angioplasty, with an equivalent safety at 30 days,...
Real-time imaging: Ultrasound detects a biodegradable embolic microsphere after prostatic artery...
Researchers report the use of ultrasound to detect embolization in real time for patients undergoing treatment for benign prostatic hyperplasia (BPH). Richard Owen (University...
Five-year evaluation of Zilver PTX stent in a real-world population continues...
Five-year results from a Japanese post-market surveillance study aimed at evaluating the Zilver PTX drug-eluting stent (DES) in a real-world population show consistently positive...
Novel approach in treating stenotic peripheral arteries shown to be safe...
Twelve-month data prove that intravascular lithotripsy; a novel approach using pulsatile sonic pressure waves to modify intimal and medium calcium in stenotic peripheral arteries,...
Lutonix Global AV Registry: DCB use prolongs time to reintervention in...
Tobias Steinke (Dusseldorf, Germany) reported on the Lutonix Global arteriovenous (AV) Registry at CIRSE 2018 in Lisbon, Portugal. Lutonix Global AV Registry data add to...
Late-breaking trial at CIRSE shows similar outcomes for severely versus non-severely...
Data from a study seeking to determine the impact of severe calcification and 12-month outcomes of femoropopliteal disease treatment using the Stellarex drug-coated balloon...
Use of snuffbox technique for distal radial access expands due to...
Darren Klass (Vancouver, Canada) tells Interventional News that social media is helping spread the word about the back hand approach for distal radial access....
Eluvia outperforms Zilver PTX in IMPERIAL 12-month results
The Eluvia drug-eluting vascular stent system (Boston Scientific) shows superior primary patency compared to the Zilver PTX drug-eluting stent (Cook Medical), concludes the 12-month...
ICEfx cryoablation system launches globally at CIRSE 2018
BTG has announced the global launch of its ICEfx cryoablation system. This is an evolution of the existing Visual ICE system, and according to...
